HighTide Therapeutics Inc (2511.HK)

HKD 1.11

(14.43%)

Operating Expenses Summary of HighTide Therapeutics Inc

  • HighTide Therapeutics Inc's latest annual operating expenses in 2023 was 438.33 Million CNY , up 73.81% from previous year.
  • HighTide Therapeutics Inc's latest quarterly operating expenses in 2024 Q2 was 133.25 Thousand HKD , down -0.15% from previous quarter.
  • HighTide Therapeutics Inc reported a annual operating expenses of 261.42 Million CNY in annual operating expenses 2022, up 66.24% from previous year.
  • HighTide Therapeutics Inc reported a annual operating expenses of 157.26 Million CNY in annual operating expenses 2021, down 0.0% from previous year.
  • HighTide Therapeutics Inc reported a quarterly operating expenses of 134.4 Thousand HKD for 2024 Q1, down -99.95% from previous quarter.
  • HighTide Therapeutics Inc reported a quarterly operating expenses of 98.35 Thousand HKD for 2023 Q1, down -99.93% from previous quarter.

Annual Operating Expenses Chart of HighTide Therapeutics Inc (2023 - 2021)

Historical Annual Operating Expenses of HighTide Therapeutics Inc (2023 - 2021)

Year Operating Expenses Operating Expenses Growth
2023 438.33 Million CNY 73.81%
2022 261.42 Million CNY 66.24%
2021 157.26 Million CNY 0.0%

Peer Operating Expenses Comparison of HighTide Therapeutics Inc

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD -34.852%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 40.706%